BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

855 related articles for article (PubMed ID: 23574725)

  • 21. Monocarboxylate transporters MCT1 and MCT4 are independent prognostic biomarkers for the survival of patients with clear cell renal cell carcinoma and those receiving therapy targeting angiogenesis.
    Cao YW; Liu Y; Dong Z; Guo L; Kang EH; Wang YH; Zhang W; Niu HT
    Urol Oncol; 2018 Jun; 36(6):311.e15-311.e25. PubMed ID: 29657088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinically relevant HIF-1α-dependent metabolic reprogramming in oropharyngeal squamous cell carcinomas includes coordinated activation of CAIX and the miR-210/ISCU signaling axis, but not MCT1 and MCT4 upregulation.
    Sáenz-de-Santa-María I; Bernardo-Castiñeira C; Secades P; Bernaldo-de-Quirós S; Rodrigo JP; Astudillo A; Chiara MD
    Oncotarget; 2017 Feb; 8(8):13730-13746. PubMed ID: 28099149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monocarboxylate transporters in cancer.
    Payen VL; Mina E; Van Hée VF; Porporato PE; Sonveaux P
    Mol Metab; 2020 Mar; 33():48-66. PubMed ID: 31395464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ethanol exposure induces the cancer-associated fibroblast phenotype and lethal tumor metabolism: implications for breast cancer prevention.
    Sanchez-Alvarez R; Martinez-Outschoorn UE; Lin Z; Lamb R; Hulit J; Howell A; Sotgia F; Rubin E; Lisanti MP
    Cell Cycle; 2013 Jan; 12(2):289-301. PubMed ID: 23257780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual Inhibition of the Lactate Transporters MCT1 and MCT4 Is Synthetic Lethal with Metformin due to NAD+ Depletion in Cancer Cells.
    Benjamin D; Robay D; Hindupur SK; Pohlmann J; Colombi M; El-Shemerly MY; Maira SM; Moroni C; Lane HA; Hall MN
    Cell Rep; 2018 Dec; 25(11):3047-3058.e4. PubMed ID: 30540938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of streptozotocin-induced diabetes on markers of skeletal muscle metabolism and monocarboxylate transporter 1 to monocarboxylate transporter 4 transporters.
    Py G; Lambert K; Milhavet O; Eydoux N; Préfaut C; Mercier J
    Metabolism; 2002 Jul; 51(7):807-13. PubMed ID: 12077722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Testosterone increases lactate transport, monocarboxylate transporter (MCT) 1 and MCT4 in rat skeletal muscle.
    Enoki T; Yoshida Y; Lally J; Hatta H; Bonen A
    J Physiol; 2006 Nov; 577(Pt 1):433-43. PubMed ID: 16959859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD147 regulates the expression of MCT1 and lactate export in multiple myeloma cells.
    Walters DK; Arendt BK; Jelinek DF
    Cell Cycle; 2013 Oct; 12(19):3175-83. PubMed ID: 24013424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monocarboxylate transporters 1-4 in NSCLC: MCT1 is an independent prognostic marker for survival.
    Eilertsen M; Andersen S; Al-Saad S; Kiselev Y; Donnem T; Stenvold H; Pettersen I; Al-Shibli K; Richardsen E; Busund LT; Bremnes RM
    PLoS One; 2014; 9(9):e105038. PubMed ID: 25225794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monocarboxylate transporter-1 (MCT1) protein expression in head and neck cancer affects clinical outcome.
    Leu M; Kitz J; Pilavakis Y; Hakroush S; Wolff HA; Canis M; Rieken S; Schirmer MA
    Sci Rep; 2021 Feb; 11(1):4578. PubMed ID: 33633176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional heterogeneity of MCT1 and MCT4 in metabolic reprogramming affects osteosarcoma growth and metastasis.
    Sheng G; Gao Y; Wu H; Liu Y; Yang Y
    J Orthop Surg Res; 2023 Feb; 18(1):131. PubMed ID: 36814318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activity of the monocarboxylate transporter 1 inhibitor AZD3965 in small cell lung cancer.
    Polański R; Hodgkinson CL; Fusi A; Nonaka D; Priest L; Kelly P; Trapani F; Bishop PW; White A; Critchlow SE; Smith PD; Blackhall F; Dive C; Morrow CJ
    Clin Cancer Res; 2014 Feb; 20(4):926-937. PubMed ID: 24277449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coexpression of MCT1 and MCT4 in ALK-positive Anaplastic Large Cell Lymphoma: Diagnostic and Therapeutic Implications.
    Choi JW; Lee Y; Kim H; Cho HY; Min SK; Kim YS
    Am J Surg Pathol; 2022 Feb; 46(2):241-248. PubMed ID: 34619707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibroblast-epithelial metabolic coupling in laryngeal cancer.
    Cao ZZ; Bao YY; Chen Z; Sheng LF; Zhou SH; Huang YP; Fan J
    Pathol Res Pract; 2022 Dec; 240():154177. PubMed ID: 36327815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of lactate/H⁺ symporters MCT1 and MCT4 and their chaperone CD147 predicts tumor progression in clear cell renal cell carcinoma: immunohistochemical and The Cancer Genome Atlas data analyses.
    Kim Y; Choi JW; Lee JH; Kim YS
    Hum Pathol; 2015 Jan; 46(1):104-12. PubMed ID: 25456395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The expression of lactate transporters (MCT1 and MCT4) in heart and muscle.
    Bonen A
    Eur J Appl Physiol; 2001 Nov; 86(1):6-11. PubMed ID: 11820324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical evaluation and prognostic value of monocarboxylate transporter 1 (MCT1) and 4 (MCT4) in T-cell non-Hodgkin lymphoma.
    Zhao H; Chen Y; Liao YP; Chen HM; Yang QH; Xiao Y; Luo J; Chen ZZ; Yi L; Hu GY
    Clin Exp Med; 2023 Feb; 23(1):55-64. PubMed ID: 35239073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monocarboxylate Transporter 4 in Cancer-Associated Fibroblasts Is a Driver of Aggressiveness in Aerodigestive Tract Cancers.
    Domingo-Vidal M; Whitaker-Menezes D; Mollaee M; Lin Z; Tuluc M; Philp N; Johnson JM; Zhan T; Curry J; Martinez-Outschoorn U
    Front Oncol; 2022; 12():906494. PubMed ID: 35814364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitochondrial fission induces glycolytic reprogramming in cancer-associated myofibroblasts, driving stromal lactate production, and early tumor growth.
    Guido C; Whitaker-Menezes D; Lin Z; Pestell RG; Howell A; Zimmers TA; Casimiro MC; Aquila S; Ando' S; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
    Oncotarget; 2012 Aug; 3(8):798-810. PubMed ID: 22878233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BRCA1 mutations drive oxidative stress and glycolysis in the tumor microenvironment: implications for breast cancer prevention with antioxidant therapies.
    Martinez-Outschoorn UE; Balliet R; Lin Z; Whitaker-Menezes D; Birbe RC; Bombonati A; Pavlides S; Lamb R; Sneddon S; Howell A; Sotgia F; Lisanti MP
    Cell Cycle; 2012 Dec; 11(23):4402-13. PubMed ID: 23172369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.